MAPKAPK5, A NOVEL MITOGEN-ACTIVATED PROTEIN-KINASE (MAPK)-ACTIVATED PROTEIN-KINASE, IS A SUBSTRATE OF THE EXTRACELLULAR-REGULATED KINASE (ERK) AND P38 KINASE
H. Ni et al., MAPKAPK5, A NOVEL MITOGEN-ACTIVATED PROTEIN-KINASE (MAPK)-ACTIVATED PROTEIN-KINASE, IS A SUBSTRATE OF THE EXTRACELLULAR-REGULATED KINASE (ERK) AND P38 KINASE, Biochemical and biophysical research communications, 243(2), 1998, pp. 492-496
A novel protein kinase that has significant sequence homology to mitog
en-activated protein kinase (MAPK)-activated protein kinase (MAPKAPK)
was identified. This novel protein kinase has a nucleotide sequence th
at encodes a protein of 473 amino acids and shares 45%, 46%, and 44% a
mino acid sequence identities to MAPKAPK2, 3 and 4 respectively. North
ern blot analysis revealed that it has a wide tissue distribution. Thi
s novel protein kinase designated MAPKAPK5 can be phosphorylated by ex
tracellular-regulated kinase (ERK), and p38 kinase but not by c-jun N-
terminal kinase (JNK) in vitro. Recombinant GST-MAPKAPK5 protein can p
hosphorylate a peptide derived from the regulatory light chain of myos
in II. Phosphorylation of MAPKAPK5 by ERK and p38 kinase increased its
activity by 9 and 15 fold respectively. Taken together, these data su
ggest that MAPKAPK5 is a novel in vitro substrate for ERK and p38 kina
se. (C) 1998 Academic Press.